Millions of Americans will board planes and travel long distances this holiday season, many of them living with known heart disease, many others quietly carrying dangerous plaque they don’t even know is there. And the risk most people are watching, cholesterol, is not actually the one most likely to trigger the life-changing event.
Millions of Americans will board planes and travel long distances this holiday season, many of them living with known heart disease, many others quietly carrying dangerous plaque they don’t even know is there. And the risk most people are watching, cholesterol, is not actually the one most likely to trigger the life-changing event.
Millions of Americans will board planes and travel long distances this holiday season, many of them living with known heart disease, many others quietly carrying dangerous plaque they don’t even know is there. And the risk most people are watching, cholesterol, is not actually the one most likely to trigger the life-changing event.
Millions of Americans will board planes and travel long distances this holiday season, many of them living with known heart disease, many others quietly carrying dangerous plaque they don’t even know is there. And the risk most people are watching, cholesterol, is not actually the one most likely to trigger the life-changing event.
Millions of Americans will board planes and travel long distances this holiday season, many of them living with known heart disease, many others quietly carrying dangerous plaque they don’t even know is there. And the risk most people are watching, cholesterol, is not actually the one most likely to trigger the life-changing event.
Millions of Americans will board planes and travel long distances this holiday season, many of them living with known heart disease, many others quietly carrying dangerous plaque they don’t even know is there. And the risk most people are watching, cholesterol, is not actually the one most likely to trigger the life-changing event.
HealthDay News — One-third of congenital cytomegalovirus (CMV)-related hearing loss would be missed without universal screening programs, according to a study published in the November issue of Otolaryngology–Head and Neck Surgery.
We describe a novel strategy of nasal intermittent positive pressure ventilation (NIPPV) to support patients with Grade 3 bronchopulmonary dysplasia (BPD).
